Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Growth Projections For The Single-Cell Analysis Transcriptomics Market Size During 2025–2029?
The market encompassing single-cell analysis transcriptomics has experienced swift expansion lately, projected to increase its valuation from $0.97 billion in the year 2024 to $1.08 billion by 2025, reflecting a compound annual growth rate (CAGR) of 11.9%. This historical period of expansion is primarily fueled by several factors: the ascending requirement for treatments tailored to individual patients, a higher incidence of both long-term and infrequently occurring illnesses, the advent of bespoke medical approaches, a growing need for sequencing technologies capable of handling large volumes of data, and the broader implementation of these techniques within cancer studies.
Anticipating substantial expansion, the market for single-cell analysis transcriptomics is projected to reach a valuation of $1.72 billion by the year 2029, demonstrating a robust compound annual growth rate (CAGR) of 12.2% across the subsequent years, this upward trajectory is chiefly motivated by the broadening utilization within the fields of immunology and neurology, the escalating deployment in creating and testing pharmaceuticals, the wider embrace of personalized healthcare methodologies, supportive actions from governmental bodies towards genomic studies, and the increased accessibility regarding the costs associated with sequencing innovations. Significant movements shaping this market moving forward encompass enhancements in both microfluidic systems and the platforms used for sequencing, the incorporation of artificial intelligence capabilities for data interpretation, the evolution towards multi-omics research strategies, novel developments concerning methods for isolating single cells, and an increasing concentration on spatial transcriptomics research.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24400&type=smp
What Are The Top Growth Drivers Impacting The Single-Cell Analysis Transcriptomics Market Outlook?
The expanding utilization of medical strategies tailored to individual needs is projected to boost the single-cell analysis transcriptomics market moving ahead; this tailored medical approach involves customizing therapies based on a person’s unique genetic makeup, daily habits, and surroundings, driven by progress in genetic sequencing that allows for treatments optimized for a person’s specific genes to yield superior outcomes, and since single-cell analysis transcriptomics reveals distinct gene expression patterns, it directly informs these customized treatments using a patient’s particular biological data, subsequently improving how well therapies work, reducing adverse reactions, and facilitating the detection of illnesses at earlier stages, which is supported by the fact that in February 2024, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration gave the green light to sixteen novel personalized therapies targeting individuals with uncommon conditions throughout 2023, a considerable rise from the six such approvals issued in 2022, thus demonstrating that greater uptake of individualized healthcare actively pushes the expansion of the single-cell analysis transcriptomics sector.
What Are The Emerging Segments Gaining Attention In The Single-Cell Analysis Transcriptomics Market?
The single-cell analysis transcriptomicsmarket covered in this report is segmented –
1) By Component: Equipment, Consumables, Software And Services
2) By Technology: Single-Cell Ribonucleic Acid (RNA) Sequencing, Microfluidics-Based Techniques, Other Technologies
3) By Application: Clinical Diagonstics, Developmental Biology, Drug Discovery, Other Applications
4) By End-User: Academic And Research Institutions, Hospitals And Diagonstic Centers, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Equipment: Ribonucleic Acid (RNA) Sequencers, Polymerase Chain Reaction (PCR) Machines, Microarray Instruments, Electrophoresis Systems, Flow Cytometers, Imaging Systems
2) By Consumables: Reagents And Kits, Ribonucleic Acid (RNA) Extraction Kits, Microarray Chips, Sequencing Chips, Complementary DNA (cDNA) Synthesis Kits, Library Preparation Kits, Enzymes And Buffers
3) By Software And Services: Data Analysis Software, Transcriptome Assembly Software, Cloud-Based Solutions, Bioinformatics Services, Data Management Tools, Custom Analysis Services, Technical Support And Training
Which Competitive Trends Are Defining The Single-Cell Analysis Transcriptomics Market Structure?
Key industry players within the single-cell analysis transcriptomics sector are concentrating their efforts on creating novel offerings, specifically single-cell RNA sequencing kits, designed to simplify laboratory procedures and facilitate more profound understandings of how cells differ from one another. These specialized single-cell RNA sequencing kits serve as essential instrumentation for isolating and examining gene expression patterns in individual cells, thereby enabling scientists to reveal cellular variations and enrich their knowledge of intricate biological mechanisms; an illustration of this is the introduction by Fluent BioSciences Inc., an American biotech firm concentrating on single-cell analysis and molecular research methods, in June 2022, of their PIPseq T2 and T20 v3.0 kits, capable of capturing anywhere from 2,000 to 20,000 single cells or nuclei per assay, presenting a sensitive, adaptable, and scalable transcriptomic analysis solution appropriate for both research involving limited cellular diversity and extensive profiling of solid tissues, while also standing out as an economically viable and readily available single-cell RNA sequencing option.
Who Are The Prominent Global Companies Shaping The Single-Cell Analysis Transcriptomics Market?
Major companies operating in the single-cell analysis transcriptomics market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc., Sartorius Aktiengesellschaft, Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., 10x Genomics Inc., Abcam Limited, Novogene Co. Ltd., Standard BioTools Inc., Akoya Biosciences Inc., Parse Biosciences Inc., Cell Microsystems Inc., Mission Bio Inc., Relation Therapeutics Ltd., CYTENA GmbH, Fluent BioSciences
Download The Full Report For Exclusive Market Findings:
Which Region Currently Holds The Largest Share Of The Single-Cell Analysis Transcriptomics Market?
North America was the largest region in the single-cell analysis transcriptomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell analysis transcriptomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Single-Cell Analysis Transcriptomics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=24400&type=smp
Browse Through More Reports Similar to the Global Single-Cell Analysis Transcriptomics Market 2025, By The Business Research Company
Single Cell Analysis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/single-cell-analysis-global-market-report
Single Cell Analysis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/single-cell-analysis-global-market-report
Single Cell Omics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model